Tine Henrichsen Schnack

Medicine & Life Sciences

1. Ovarian Epithelial Carcinoma 100%
2. Ovarian Neoplasms 48%
3. Vulvar Neoplasms 42%
4. Survival 42%
5. Carcinoma 34%
6. Clear Cell Adenocarcinoma 30%
7. Neoplasms 28%
8. Uterine Cervical Neoplasms 27%
9. Groin 27%
10. Endometriosis 21%
11. Recurrence 21%
12. Demography 19%
13. Comparative Histology 19%
14. Gynecology 18%
15. Adenocarcinoma 18%
16. Obstetrics 16%
17. Lymph Node Excision 16%
18. Lymph Nodes 16%
19. Epididymis 16%
20. Neoplasm Metastasis 15%
21. Physicians' Practice Patterns 15%
22. Systematic Reviews 14%
23. Residual Neoplasm 13%
24. Databases 13%
25. Pelvic Inflammatory Disease 13%
26. Mutation 12%
27. Denmark 12%
28. Population 12%
29. Progression-Free Survival 11%
30. Minimally Invasive Surgical Procedures 11%
31. Carcinogenesis 11%
32. Cytomegalovirus 11%
33. Adjuvant Chemotherapy 11%
34. Tumor Burden 10%
35. Robotics 10%
36. Incidence 10%
37. Therapeutics 10%
38. Human Herpesvirus 4 10%
39. Guidelines 9%
40. Intubation 9%
41. Practice Guidelines 9%
42. Positron-Emission Tomography 9%
43. DNA 9%
44. Histology 8%
45. Exons 8%
46. Squamous Cell Neoplasms 8%
47. Radiotherapy 8%
48. Colorectal Neoplasms 8%
49. Confidence Intervals 7%
50. Survival Rate 7%